Sustained measles transmission driven by vaccination gaps below the 95% herd immunity threshold continues to fuel record U.S. case counts in 2026. As of August 13, the CDC reports 2,566 confirmed cases—already exceeding the full-year 2025 total of 2,289 and marking the highest annual figure since 1991—with 38 new outbreaks and 94% of infections outbreak-associated across 47 jurisdictions. Most cases involve unvaccinated individuals, including 20% under age 5, reflecting imported introductions and local chains in under-immunized communities. CDC weekly updates and state surveillance reports will shape trader views on whether totals remain elevated through year-end, while any Pan American Health Organization review of elimination status could highlight ongoing risks from declining routine MMR coverage.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · ОновленоВипадки кору в США в 2026 році?
Випадки кору в США в 2026 році?
$7,830,948 Обс.
$7,830,948 Обс.
Dec 31, 2026
↑4.5k
42%
↑3к
95%
↑3.5k
92%
↑4к
75%
↑5к
26%
↑7,5 тис.
12%
↑10 тис.
6%
↑12,5 тис.
5%
$7,830,948 Обс.
$7,830,948 Обс.
Dec 31, 2026
↑4.5k
$20 Обс.
42%
↑3к
$90,114 Обс.
95%
↑3.5k
$13,530 Обс.
92%
↑4к
$220,549 Обс.
75%
↑5к
$230,428 Обс.
26%
↑7,5 тис.
$185,031 Обс.
12%
↑10 тис.
$6,515,593 Обс.
6%
↑12,5 тис.
$349,917 Обс.
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained measles transmission driven by vaccination gaps below the 95% herd immunity threshold continues to fuel record U.S. case counts in 2026. As of August 13, the CDC reports 2,566 confirmed cases—already exceeding the full-year 2025 total of 2,289 and marking the highest annual figure since 1991—with 38 new outbreaks and 94% of infections outbreak-associated across 47 jurisdictions. Most cases involve unvaccinated individuals, including 20% under age 5, reflecting imported introductions and local chains in under-immunized communities. CDC weekly updates and state surveillance reports will shape trader views on whether totals remain elevated through year-end, while any Pan American Health Organization review of elimination status could highlight ongoing risks from declining routine MMR coverage.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Ринок відкрито: Feb 16, 2026, 11:51 AM ET
Обсяг
$7,830,948Дата завершення
Dec 31, 2026Ринок відкрито
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained measles transmission driven by vaccination gaps below the 95% herd immunity threshold continues to fuel record U.S. case counts in 2026. As of August 13, the CDC reports 2,566 confirmed cases—already exceeding the full-year 2025 total of 2,289 and marking the highest annual figure since 1991—with 38 new outbreaks and 94% of infections outbreak-associated across 47 jurisdictions. Most cases involve unvaccinated individuals, including 20% under age 5, reflecting imported introductions and local chains in under-immunized communities. CDC weekly updates and state surveillance reports will shape trader views on whether totals remain elevated through year-end, while any Pan American Health Organization review of elimination status could highlight ongoing risks from declining routine MMR coverage.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Обсяг
$7,830,948Дата завершення
Dec 31, 2026Ринок відкрито
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...Sustained measles transmission driven by vaccination gaps below the 95% herd immunity threshold continues to fuel record U.S. case counts in 2026. As of August 13, the CDC reports 2,566 confirmed cases—already exceeding the full-year 2025 total of 2,289 and marking the highest annual figure since 1991—with 38 new outbreaks and 94% of infections outbreak-associated across 47 jurisdictions. Most cases involve unvaccinated individuals, including 20% under age 5, reflecting imported introductions and local chains in under-immunized communities. CDC weekly updates and state surveillance reports will shape trader views on whether totals remain elevated through year-end, while any Pan American Health Organization review of elimination status could highlight ongoing risks from declining routine MMR coverage.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · Оновлено
Обережно з зовнішніми посиланнями.
Обережно з зовнішніми посиланнями.
Часті запитання